The Patent Finder

Endocyte, Inc.

14 patents currently held · Updated Nov 21, 2026
6 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 3 name spellings.

4
Ending by 2030
Sep 2029
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Mar 24, 2027
    The maintenance fee for Method of imaging with a chelating agent (US 10,420,850) comes due Mar 24, 2027. Unpaid by Sep 24, 2027, it lapses early.
  • 1 fee due May 24, 2027
    The maintenance fee for Folate receptor binding conjugates of antifolates (US 9,192,682) comes due May 24, 2027. Unpaid by Nov 24, 2027, it lapses early.
  • 1 fee due Oct 21, 2027
    The maintenance fee for Conjugates for treating diseases (US 10,624,972) comes due Oct 21, 2027. Unpaid by Apr 21, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 1 term has ended since Aug 23, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,546,425Folate receptor binding conjugates of antifolates
In force (reinstated)
 · USPTO record
In force (reinstated)USPTO record
US 9,192,682Folate receptor binding conjugates of antifolates
In force
 · USPTO record
In forceUSPTO record
US 9,549,992Folate Receptor Binding Conjugates of Antifolates
In force
 · Medium confidence
In forceMedium confidence
US 11,219,622Folate Receptor Binding Conjugates of Antifolates
In force
 · Medium confidence
In forceMedium confidence
US 9,636,413Conjugates for Treating Diseases Caused by Psma Expressing Cells
In force
 · High confidence
In forceHigh confidence
US 9,782,493Conjugates for Treating Diseases Caused by Psma Expressing Cells
In force
 · High confidence
In forceHigh confidence
US 10,912,840Conjugates for Treating Diseases Caused by Psma Expressing Cells
In force
 · High confidence
In forceHigh confidence
US 10,624,972Conjugates for treating diseases
In force
 · USPTO record
In forceUSPTO record
US 12,178,892Compounds for Positron Emission Tomography
In force
 · High confidence
In forceHigh confidence
US 10,188,759Conjugates for imaging
In force
 · USPTO record
In forceUSPTO record
10 of 14 patents shown.
Pro members see all 14.
Pro members: see all 14 patents
Also on record, not counted in the 14: 6 patents in force now held by others · 33 lapsed for an unpaid fee · 8 ended at full term · 1 surrendered on reissue. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

11 pending · 18 abandoned · 45 no status recorded

Showing 1 to 10 of 74, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page.

ApplicationTitleFiledStatus
19/067,642Methods of Use for Car T CellsFeb 28, 2025Pending
18/999,436Methods of Treating CancerDec 23, 2024Pending
18/963,158Sequencing Method for Car T Cell TherapyNov 27, 2024Pending
18/914,891Methods and Compositions for Car T Cell TherapyOct 14, 2024Pending
18/913,734Compounds for Positron Emission TomographyOct 11, 2024Pending
18/906,001Conjugates for Treating Diseases Caused by Psma Expressing CellsOct 3, 2024Pending
18/823,426Methods of Treating Cancer by Targeting Tumor-Associated MacrophagesSep 3, 2024Pending
18/494,613Compositions and Methods for Car T Cell TherapyOct 25, 2023Pending
17/737,471Conjugates for Treating Diseases Caused by Psma Expressing CellsMay 5, 2022Abandoned
17/524,211Methods of Treating Cancer by Targeting Tumor-Associated MacrophagesNov 11, 2021Abandoned
10 of 74 applications shown.
Pro members see all 74 published applications.
Pro members: see all 74 applications
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited